150 related articles for article (PubMed ID: 27383140)
1. Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.
Tietz O; Kaur J; Bhardwaj A; Wuest FR
Org Biomol Chem; 2016 Jul; 14(30):7250-7. PubMed ID: 27383140
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors.
Tietz O; Dzandzi J; Bhardwaj A; Valliant JF; Wuest F
Bioorg Med Chem Lett; 2016 Mar; 26(6):1516-1520. PubMed ID: 26898334
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity.
Bansal S; Bala M; Suthar SK; Choudhary S; Bhattacharya S; Bhardwaj V; Singla S; Joseph A
Eur J Med Chem; 2014 Jun; 80():167-74. PubMed ID: 24780593
[TBL] [Abstract][Full Text] [Related]
5. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
Bhardwaj A; Kaur J; Wuest F; Knaus EE
ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
[TBL] [Abstract][Full Text] [Related]
6. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
7. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold.
Tietz O; Sharma SK; Kaur J; Way J; Marshall A; Wuest M; Wuest F
Org Biomol Chem; 2013 Dec; 11(46):8052-64. PubMed ID: 24145766
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2).
Kaur J; Tietz O; Bhardwaj A; Marshall A; Way J; Wuest M; Wuest F
ChemMedChem; 2015 Oct; 10(10):1635-40. PubMed ID: 26287271
[TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.
Sever B; Altıntop MD; Özdemir A; Akalın Çiftçi G; Ellakwa DE; Tateishi H; Radwan MO; Ibrahim MAA; Otsuka M; Fujita M; Ciftci HI; Ali TFS
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171861
[TBL] [Abstract][Full Text] [Related]
11. Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors.
Orjales A; Mosquera R; López B; Olivera R; Labeaga L; Núñez MT
Bioorg Med Chem; 2008 Mar; 16(5):2183-99. PubMed ID: 18158247
[TBL] [Abstract][Full Text] [Related]
12. Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.
Swarbrick ME; Beswick PJ; Gleave RJ; Green RH; Bingham S; Bountra C; Carter MC; Chambers LJ; Chessell IP; Clayton NM; Collins SD; Corfield JA; Hartley CD; Kleanthous S; Lambeth PF; Lucas FS; Mathews N; Naylor A; Page LW; Payne JJ; Pegg NA; Price HS; Skidmore J; Stevens AJ; Stocker R; Stratton SC; Stuart AJ; Wiseman JO
Bioorg Med Chem Lett; 2009 Aug; 19(15):4504-8. PubMed ID: 19520573
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors.
Kaya Çavuşoğlu B; Sağlık BN; Acar Çevik U; Osmaniye D; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000273. PubMed ID: 33244799
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (β-lactams) as selective cyclooxygenase-2 inhibitors.
Arefi H; Naderi N; Shemirani ABI; Kiani Falavarjani M; Azami Movahed M; Zarghi A
Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900293. PubMed ID: 31917485
[TBL] [Abstract][Full Text] [Related]
18. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
20. A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activity.
Hughes TV; Xu G; Wetter SK; Connolly PJ; Emanuel SL; Karnachi P; Pollack SR; Pandey N; Adams M; Moreno-Mazza S; Middleton SA; Greenberger LM
Bioorg Med Chem Lett; 2008 Sep; 18(17):4896-9. PubMed ID: 18678484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
